Universidad Nacional de Córdoba, Av. Maipú 177 4°, B - 5000, Córdoba, Argentina.
Service d'Odontologie, CHU Clermont-Ferrand, Université Clermont Auvergne, CROC EA4847, Clermont-Ferrand, France.
Clin Oral Investig. 2018 Jan;22(1):461-467. doi: 10.1007/s00784-017-2134-y. Epub 2017 May 25.
To assess the 3-year cumulative survival rate of atraumatic restorative treatment (ART) and conventional resin composite restorations (CRT) placed in persons with disability.
Patients referred for restorative care to the Haemophilia Foundation special care service were treated by one of two specialists. Patients and/or caregivers were provided with written and verbal information regarding treatment options and selected the alternative they preferred. Treatment was provided as selected unless this option proved clinically unfeasible when an alternative technique was proposed. The treatment protocols were ART (hand instruments/high-viscosity glass-ionomer) in the clinic or CRT (rotary instrumentation/resin composite) in the clinic or under general anaesthesia (GA). After 6, 12, 24 and 36 months, two independent, trained and calibrated examiners evaluated restoration survival using established ART codes. The proportional hazard model with frailty corrections gave survival estimates over 3 years.
Sixty-six patients (13.6 ± 7.8 years) with 16 different disability profiles participated. CRT in the clinic proved feasible for five patients (13%), and 14 patients received CRT under GA (21%). ART was used for 47 patients (71.2%). Altogether, 298 dentine carious lesions were restored in primary and permanent teeth (182 ART; 116 CRT). The 3-year cumulative survival rates and jackknife standard errors for the 182 ART and 116 CRT restorations were 94.8 ± 2.1 and 82.8 ± 5.3%, respectively (p = 0.01).
The 3-year follow-up results confirm that ART is an effective treatment protocol.
Patients with disability, many of whom have difficulty coping with CRT, may benefit from the ART approach.
评估在残疾患者中使用无创伤性修复治疗(ART)和传统树脂复合材料修复(CRT)的 3 年累积存活率。
将需要修复治疗的患者转介到血友病基金会特殊护理服务,由两位专家之一进行治疗。向患者和/或护理人员提供关于治疗选择的书面和口头信息,并选择他们喜欢的替代方案。除非另一种技术在临床上不可行,否则会按照所选方案进行治疗,然后提出替代方案。治疗方案为诊所内的 ART(手动器械/高粘度玻璃离子体)或 CRT(旋转器械/树脂复合材料)或全身麻醉(GA)下的 CRT。在 6、12、24 和 36 个月后,两名独立的、经过培训和校准的检查者使用既定的 ART 编码评估修复体的存活率。带有脆弱性校正的比例风险模型给出了 3 年的生存估计。
66 名患者(13.6±7.8 岁)有 16 种不同的残疾类型,5 名患者(13%)在诊所内接受 CRT,14 名患者接受 GA 下的 CRT(21%)。47 名患者接受了 ART(71.2%)。总共在恒牙和乳牙中修复了 298 个牙本质龋损(182 个 ART;116 个 CRT)。182 个 ART 和 116 个 CRT 修复体的 3 年累积存活率和刀切标准误分别为 94.8±2.1%和 82.8±5.3%(p=0.01)。
3 年随访结果证实 ART 是一种有效的治疗方案。
许多残疾患者难以接受 CRT,他们可能受益于 ART 方法。